Deciphera Pharmaceuticals, Inc. (DCPH)
NASDAQ: DCPH · IEX Real-Time Price · USD
14.66
+0.48 (3.39%)
Apr 26, 2024, 2:44 PM EDT - Market open
Deciphera Pharmaceuticals Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for DCPH stock have an average target of 23, with a low estimate of 16 and a high estimate of 30. The average target predicts an increase of 56.89% from the current stock price of 14.66.
Analyst Consensus: Strong Buy
* Price targets were last updated on Mar 20, 2024.
Analyst Ratings
The average analyst rating for DCPH stock from 6 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 3 | 3 | 3 |
| Buy | 4 | 4 | 4 | 3 | 2 | 2 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 1 | 1 | 1 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 10 | 10 | 7 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JP Morgan | JP Morgan | Hold Maintains $14 → $16 | Hold | Maintains | $14 → $16 | +9.14% | Mar 20, 2024 |
| Stifel | Stifel | Strong Buy Maintains $22 → $23 | Strong Buy | Maintains | $22 → $23 | +56.89% | Feb 7, 2024 |
| JP Morgan | JP Morgan | Hold Initiates $14 | Hold | Initiates | $14 | -4.50% | Nov 20, 2023 |
| Stifel | Stifel | Strong Buy Maintains $20 → $22 | Strong Buy | Maintains | $20 → $22 | +50.07% | Oct 31, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $25 → $30 | Strong Buy | Maintains | $25 → $30 | +104.64% | Oct 31, 2023 |
Financial Forecast
Revenue This Year
204.27M
from 163.36M
Increased by 25.05%
Revenue Next Year
261.54M
from 204.27M
Increased by 28.04%
EPS This Year
-2.21
from -2.29
EPS Next Year
-1.74
from -2.21
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 217.8M | 416.9M | 756.5M | 529.9M | 703.5M |
| Avg | 204.3M | 261.5M | 372.1M | 428.7M | 531.8M |
| Low | 183.0M | 211.6M | 239.1M | 250.5M | 313.6M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 33.3% | 104.1% | 189.3% | 42.4% | 64.1% |
| Avg | 25.0% | 28.0% | 42.3% | 15.2% | 24.0% |
| Low | 12.0% | 3.6% | -8.6% | -32.7% | -26.8% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -1.85 | -0.56 | 1.60 | 0.13 | 2.10 |
| Avg | -2.21 | -1.74 | -0.87 | -0.47 | 0.65 |
| Low | -2.54 | -2.34 | -1.86 | -1.53 | -0.36 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | - |
| Avg | - | - | - | - | - |
| Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.